Abstract:Post-marketing surveillance is the principal means to ensure drug use safety. The spontaneous report is the essential method of post-marketing surveillance for drug safety. Often, most spontaneous reports come from medical staff and sometimes come from patients who use the drug. The posts published by individuals on social media platforms that contain drugs and related adverse reaction content have gradually been seen as a new data source similar to spontaneous reports from drug users in recent years. Those user-generated posts potentially provide researchers and regulators with new opportunities to conduct post-marketing surveillance for drug safety from patients' perspectives mostly rather than medical professionals and can afford the possibility theoretically to discover drug-related safety issues earlier than traditional methods. Social media data as a new data source for safety signal detection and signal reinforcement have the unique advantages, such as population coverage, type of drugs, type of adverse reactions, data timeliness and quantity. Most of the social media data used in post-marketing surveillance research for drug safety are still text data in English, and even multiple languages are used by different people worldwide on several social media platforms. Unfortunately, there is still a controversy in the academic circles whether social media data can be used as reliable data sources for routine post-marketing surveillance for drug safety. A couple of obstacles of data, methods and ethics must be overcome before leveraging social media data for post-marketing surveillance. The number of Chinese social media users is large, and the social media data in the Chinese language is rapidly snowballing, which can be employed as the potential data source for post-marketing surveillance for drug safety. However, due to the Chinese language's specific characteristics, the text's diversity is different from the English text, and there is not enough accepted corpus in medical scenarios. Besides, the lack of domestic laws and regulations on privacy and security protection of social media data poses more challenges for applying Chinese social media data for post-market surveillance. The significance of social media data to post-marketing surveillance for drug safety is undoubtedly significant. It will be an essential development direction for future research to overcome the challenges of using social media data by developing new technologies and establishing new mechanisms.

[Active Surveillance of Adverse Drug Reaction in the Era of Big Data: Challenge and Opportunity for Control Selection].

Methodological Progress in Selection of Control in Observation Study in the Context of Big Data

Detecting Adverse Drug Event Signals from a Clinical CaseBase.

Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China

Drug Safety Signal Detection in a Regional Healthcare Database Using the Tree-Based Scan Statistic and Comparison to 3 Other Mining Methods

A Computational Method to Quantitatively Measure Pediatric Drug Safety Using Electronic Medical Records

[Utilizing social media data in post-market safety surveillance]

Application of Association Rules Analysis in Mining Adverse Drug Reaction Signals

Randomized Controlled Trial Based on Big Data

Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies

Detection of cluster adverse drug events in the spontaneous reporting system of China using a disproportionality filter algorithm

The Application of Tree-based Scan Statistic in Drug Safety Surveillance

Integrative Analysis of Randomized Clinical Trial and Observational Study Data to Inform Post-marketing Safety Decision-Making

Feasibility of Post-Marketing Active Safety Surveillance for Pediatric Medication Based on Big Medical Data: a Survey on Information Systems in 17 Children′s Hospitals in China

Detecting Pharmacovigilance Signals Combining Electronic Medical Records With Spontaneous Reports: A Case Study of Conventional Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis

A Survey on Computational Approaches to Predicting Adverse Drug Reactions.

Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data

[Methods for Controlling and Evaluating Residual Confounding in the Association Analysis of Observational Study with a Multicenter Database].

Design considerations in an active medical product safety monitoring system

Combining a Pharmacological Network Model with a Bayesian Signal Detection Algorithm to Improve the Detection of Adverse Drug Events

New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China